Precision Optics Corporation, Inc. Announces Operating

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Precision Optics Corporation, Inc. Announces Operating Results for the Third Quarter and Nine Months of Fiscal Year 2015

GARDNER, Mass., May 14, 2015 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the "Company") today announced operating results on an unaudited basis for its third quarter and nine months ended March 31, 2015, of fiscal year 2015.

Third quarter highlights include:

  • Revenues of $1.142 million, representing a 17% sequential increase over the second quarter of fiscal 2015, and a 37% increase over the third quarter of fiscal 2014;
  • Gross margin of 27.4%, an improvement compared to 16.6% in the second quarter of fiscal 2015;
  • Company responding to increasing interest in Microprecision™ optics and their use in reusable and single-use medical devices.

Commenting on the quarter's results, Precision Optics' CEO Joseph Forkey said, "We continue to see solid demand for our traditional products as well as early market acceptance of products based on our latest technology. Our third quarter revenues were the highest in over ten years. Our gross margin percentage was significantly higher than recent quarters. While some of this increase in margin is due to efficiencies of scale, much is also due to our focus over the last six months on increased manufacturing efficiencies, especially as we bring new products into production. We are maintaining this focus and broadening our efforts to drive higher margins."

Dr. Forkey concluded, "Looking forward, we continue to see a strong pipeline of opportunities, particularly in the area of micro-optics and micro-assemblies based on optics designed specifically for small CMOS-based medical camera systems. Working with major partners, we have now developed a next-generation CMOS-based medical camera which has the highest resolution of any camera with diameter in the 1 – 2 mm range. We look forward to demonstrating this new innovation at the Medical Design and Manufacturing (MD&M) exhibit which will be held in New York City, June 9 – 11, 2015. We are expanding our go-to-market efforts to ensure both large established medical device companies and small, emerging technology players see the value our newest products can offer."

Quarterly Conference Call Details

The Company has scheduled a conference call to discuss the fiscal third quarter 2015 financial results for today at 4:30 PM Eastern. To participate in the conference call, please dial 1-866-652-5200 toll free from the U.S., or 1-412-317-6060, and ask to be connected to the Precision Optics conference call.

An audio replay of the conference call will be available approximately one hour after the conclusion of the call and will be made available until August 13, 2015. The audio replay can be accessed by dialing 1-877-344-7529 toll free from the US or 1-412-317-0088, and then the replay access code of 10065931.

About Precision Optics Corporation

Precision Optics Corporation has been a leading developer and manufacturer of advanced optical instruments since 1982. Using proprietary optical technologies, the Company designs and produces next generation medical instruments, Microprecision TM micro-optics with characteristic dimensions less than 1 millimeter, and other advanced optical systems for a broad range of customers including some of the largest global medical device companies. The Company's innovative medical instrumentation line includes state-of-the-art endoscopes and endocouplers as well as custom illumination and imaging products for use in minimally invasive surgical procedures. The Company believes that current advances in its proprietary micro-optics and 3D imaging technologies present significant opportunities for expanding applications to numerous potential medical products and procedures. The Company's website is www.poci.com . Investors can find Real-Time Quotes and market information for the Company on www.otcmarkets.com/stock/PEYE/quote .

About Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company's intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company's future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by the Company's management. These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in the Company's annual report on Form 10-K and in other documents that we file from time to time with the SEC. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this report, except as required by law.

Following are the Company's consolidated balance sheets as of March 31, 2015 and June 30, 2014, and statements of operations for the three and nine months ended March 31, 2015 and 2014 and statements of cash flows for the nine months ended March 31, 2015 and 2014 (unaudited):

 
 
PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (UNAUDITED)
     
  March 31, 2015 June 30, 2014
ASSETS    
CURRENT ASSETS    
Cash and Cash Equivalents $ 283,275 $ 202,380
Accounts Receivable, net 542,473 531,049
Inventories, net 1,248,742 988,878
Prepaid Expenses 70,826 91,922
Total Current Assets 2,145,316 1,814,229
PROPERTY AND EQUIPMENT    
Machinery and Equipment 2,428,682 2,368,709
Leasehold Improvements 553,596 553,596
Furniture and Fixtures 148,303 148,303
Vehicles 19,674 19,674
  3,150,255 3,090,282
     
Less: Accumulated Depreciation (3,090,684) (3,075,722)
Net Property and Equipment 59,571 14,560
     
Patents, net 18,644 7,672
     
TOTAL ASSETS $ 2,223,531 $ 1,836,461
LIABILITIES AND STOCKHOLDERS' EQUITY    
CURRENT LIABILITIES    
Accounts Payable $ 866,706 $ 715,192
Customer Advances 100,600 26,200
Accrued Employee Compensation 234,779 200,207
Accrued Professional Services 59,052 60,250
Accrued Warranty Expense 25,000 25,000
Other Accrued Liabilities 23,034 69,028
Total Current Liabilities 1,309,171 1,095,877
STOCKHOLDERS' EQUITY    
Common Stock, $0.01 par value - Authorized - 50,000,000 shares; Issued and Outstanding –6,344,806 shares at March 31, 2015 and 4,455,134 shares at June 30, 2014 63,448 44,551
Additional Paid-in Capital 43,117,175 42,146,750
Accumulated Deficit (42,266,263) (41,450,717)
Total Stockholders' Equity 914,360 740,584
     
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,223,531 $ 1,836,461

 

 
PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2015 AND 2014 (UNAUDITED)
         
  Three Months Ended March 31, Nine Months Ended March 31,
  2015 2014 2015 2014
Revenues $ 1,141,892 $ 833,451 $ 2,949,154 $ 2,748,594
         
Cost of Goods Sold 828,963 644,219 2,361,575 2,093,712
Gross Profit 312,929 189,232 587,579 654,882
         
Research and Development Expenses, net 140,177 132,957 355,782 360,012
         
Selling, General and Administrative Expenses 410,549 443,220 1,104,466 1,146,136
         
Gain on Sale of Assets (691) (6,511) (17,901) (7,658)
Total Operating Expenses 550,035 569,666 1,442,347 1,498,490
         
Operating Loss (237,106) (380,343) (854,768) (843,608)
         
Other Income 39,222 -- 39,222 --
         
Net Loss (197,884) (380,434) (815,546) (843,608)
         
Loss Per Share:        
Basic $ (0.03) $ (0.09) $ (0.13) $ (0.19)
Diluted $ (0.03) $ (0.09) $ (0.13) $ (0.19)
         
Weighted Average Common Shares Outstanding:        
Basic 6,334,757 4,455,134 6,241,438 4,455,134
Diluted 6,334,757 4,455,134 6,241,438 4,455,134

 

PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED MARCH 31, 2015 AND 2014 (UNAUDITED)
     
  Nine Months Ended March 31,
  2015 2014
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Loss $ (815,546) $ (843,608)
Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities --    
Depreciation and Amortization 14,962 16,842
Gain on Sale of Assets (17,901) (7,658)
Stock-based Compensation Expense 42,750 108,924
Non-cash Consulting Expense 38,625 73,898
Non-cash Gain on Settlement of Liabilities by Issuing Common Stock (39,222) --
Changes in Operating Assets and Liabilities --    
Accounts Receivable, net (11,424) (203,211)
Inventories (259,864) (24,036)
Prepaid Expenses 21,096 (42,299)
Accounts Payable 165,514 254,295
Customer Advances 74,400 (10,262)
Accrued Expenses 61,770 8,257
Net Cash Used In Operating Activities (724,840) (668,858)
     
CASH FLOWS FROM INVESTING ACTIVITIES:    
Additional Patent Costs (10,972) (8,524)
Purchases of Property and Equipment (59,973) –
Proceeds from Sale of Assets 17,901 7,658
Net Cash Used In Investing Activities (53,044) (866)
     
CASH FLOWS FROM FINANCING ACTIVITIES:    
Gross Proceeds from July 2014 Private Placement of Common Stock 980,291 –
Private Placement Expenses Incurred and Paid as of March 31, 2015 (121,512) –
     
Net Cash Provided by Financing Activities 858,779 –
     
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 80,895 (669,724)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 202,380 1,034,587
     
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 283,275 $ 364,863
     
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash Paid for Income Taxes $ 912 $ 912
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:    
Issuance of 172,520 Shares of Common Stock for Services Rendered to the Company $ 93,793 $ –
Private Placement Expenses Incurred But Not Yet Paid as of March 31, 2015 $ 6,000 $ –

PRECISION OPTICS CORPORATION 22 EAST BROADWAY GARDNER, MASSACHUSETTS 01440-3338 Telephone 978 / 630-1800 Telefax 978 / 630-1487

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navan’s Travel Survey Sells Friction as a Business Case

Updated Category News Views 154

A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...

Continue Reading
A Faded Sign Is a Quiet Leak in Storefront Demand Today

Updated Category News Views 95

Sunlight does not care what the marketing budget said. A storefront can have a decent product, a clean interior and a capable crew, then lose the first impression before anyone reaches the door because its sign looks tired. That is the plainspoken point behind FASTSIGNS' latest guidance on outdoor sign lifespan. This is not glamorous stuff, but it is operationally...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 25

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 128

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Max y Noelia Explore Trade at 9th CIIE in Shanghai

Updated Category News Views 60

Influencers at the Heart of Global Trade Exploration Makin' their debut on the big stage of the 9th China International Import Expo (CIIE), Mexican influencers Max y Noelia found themselves caught in a whirlwind of trade and cultural exchanges over in Shanghai. These digital mavens aren't just snapping selfies. Nope, they're capturing the very essence of international...

Continue Reading
Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 20

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 27

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 186

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 114

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 84

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading

Top 5 Most Recently Viewed Articles

Growing FPSO Market Set to Reach $174 Billion by 2031

Updated Category News Views 101

Insights into the Floating Production Storage Offloading Market The Floating Production Storage Offloading (FPSO) market is emerging as a cornerstone in the offshore oil and gas industry. As global oil demands continue to escalate, industries and stakeholders are directing their attention towards FPSO technologies, which combine production and storage capabilities to...

Continue Reading
3D Systems Corporation Faces Potential Securities Fraud Lawsuit

Updated Category News Views 207

Potential Securities Fraud Lawsuit Against 3D Systems Corporation Investors in 3D Systems Corporation have a significant opportunity as rumors of a securities fraud lawsuit surface. This potential lawsuit is connected to claims of misleading statements made by the company regarding its financial performance and market outlook. Overview of the Allegations According to...

Continue Reading
Latest Insights into the U.S. Real Estate Landscape Today

Updated Category News Views 368

Understanding Recent Trends in U.S. Real Estate In recent months, the real estate market in the United States has demonstrated some fascinating trends. Notably, many Americans are choosing to stay in their homes rather than moving. In fact, only 11% moved in a recent year, a stark contrast to historical figures where up to a third of the population changed residences...

Continue Reading
Venture Global, Inc. Investors Encouraged to Take Action Soon

Updated Category News Views 285

Important Deadlines for Venture Global, Inc. Investors Investors of Venture Global, Inc. should pay close attention to approaching deadlines related to an ongoing securities class action. Those who purchased stock pursuant to the company's initial public offering (IPO) that took place in early 2025 have significant rights that might not require any out-of-pocket expense....

Continue Reading
Vatn Systems Makes Strategic Acquisition to Boost AUV Tech

Updated Category News Views 160

Vatn Systems' Strategic Move to Enhance Underwater Technology In an exciting development for the defense technology sector, Vatn Systems has made a significant advancement by acquiring Crewless Marine. This decision is part of Vatn's strategy to improve its autonomous underwater vehicles (AUVs), highlighting the importance of acoustic capabilities in undersea warfare....

Continue Reading